Bank of America’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $190K | Sell |
|
|||||
|
2024
Q2 | $1.82M | Buy |
|
|||||
|
2024
Q1 | $1.71M | Buy |
|
|||||
|
2023
Q4 | $978K | Buy |
|
|||||
|
2023
Q3 | $74.4K | Sell |
|
|||||
|
2023
Q2 | $249K | Sell |
|
|||||
|
2023
Q1 | $9.03M | Buy |
|
|||||
|
2022
Q4 | $1.2M | Buy |
|
|||||
|
2022
Q3 | $939K | Buy |
|
|||||
|
2022
Q2 | $146K | Sell |
|
|||||
|
2022
Q1 | $215K | Sell |
|
|||||
|
2021
Q4 | $4.72M | Buy |
|
|||||
|
2021
Q3 | $3.56M | Buy |
|
|||||
|
2021
Q2 | $2.59M | Sell |
|
|||||
|
2021
Q1 | $2.73M | Sell |
|
|||||
|
2020
Q4 | $3.14M | Sell |
|
|||||
|
2020
Q3 | $4.89M | Buy |
|
|||||
|
2020
Q2 | $3.52M | Sell |
|
|||||
|
2020
Q1 | $3.85M | Sell |
|
|||||
|
2019
Q4 | $5.06M | Sell |
|
|||||
|
2019
Q3 | $6.81M | Buy |
|
|||||
|
2019
Q2 | $5.33M | Sell |
|
|||||
|
2019
Q1 | $6.82M | Buy |
|
|||||
|
2018
Q4 | $3.06M | Buy |
|
|||||
|
2018
Q3 | $3.67M | Sell |
|
|||||
|
2018
Q2 | $5.36M | Buy |
|
|||||
|
2018
Q1 | $1.32M | Sell |
|
|||||
|
2017
Q4 | $1.56M | Sell |
|
|||||
|
2017
Q3 | $2.31M | Buy |
|
|||||
|
2017
Q2 | $1.61M | Buy |
|
|||||
|
2017
Q1 | $1.23M | Buy |
|
|||||
|
2016
Q4 | $1.15M | Buy |
|
|||||
|
2016
Q3 | $113K | Sell |
|
|||||
|
2016
Q2 | $115K | Buy |
|
|||||
|
2016
Q1 | $13K | Sell |
|
|||||
|
2015
Q4 | $783K | Buy |
|
|||||
|
2015
Q3 | $47K | Sell |
|
|||||
|
2015
Q2 | $629K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $173K | Buy |
|